The harms and benefits of modern screening mammography: Women need more balanced information

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Elmore, Joann G ^a   Harris, Russell P ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CLINICAL DECISION MAKING; EDITORIAL; FEMALE; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; MAMMOGRAPHY; MEDICAL INFORMATION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; RISK FACTOR;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY;

EID: 84902578367     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g3824     Document Type: Editorial

References (14)

1. Biller-Andorno N, Jüni P. Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med 2014;370:1965-7.
2. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012;380:1778-86.
3. Weedon-Fekjaer H, Romundstad P, Vatten LJ. Modern mammography screening and breast cancer mortality: population study. BMJ 2014;348:g3701.
4. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 2014;348:g366.
5. Harris R, Yeatts J, Kinsinger L. Breast cancer screening for women aged 50 to 69 years: a systematic review of observational evidence. Prev Med 2011;53:108-14.
6. Kalager M, Zelen M, Langmark F, Adami H-O. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010;363:1203-10.
7. Olsen AH, Lynge E, Njor SH, Kumle M, Waaseth M, Braaten T, et al. Breast cancer mortality in Norway after the introduction of mammography screening. Int J Cancer 2013;132:208-14.
8. Hofvind S, Ursin G, Tretli S, Sebuødegård S, Møller B. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program. Cancer 2013;119:3106-12.
9. Kalager M, Loberg M, Bretthauer M, Adami HO. Comparative analysis of breast cancer mortality following mammography screening in Denmark and Norway. Ann Oncol 2014;25:1137-43.
10. Hoffman RM, Lewis CL, Pignone MP, Couper MP, Barry MJ, Elmore JG, et al. Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Med Decis Making 2010;30(5 Suppl):S53S-64.
11. Ferraro N. Hastings hospital's mammogram parties offer women a dose of pampering to calm the nerves. St Paul Pioneer Press. 2011 Jan 20.
12. Hawkes N. "Citizens' jury" disagrees over whether screening leaflet should put reassurance before accuracy. BMJ 2012;345:e8047.
13. Hawkes N. Women "jurors" are asked how to present risk-benefit ratio of breast cancer screening. BMJ 2012;345:e7886.
14. Coulter A. UK citizen's jury advises on communication about the benefits and harms of breast screening. Guest blog posted by Gary Schwitzer, 2013. www.healthnewsrevieworg.